Abstract
Aim:
Currently, there is considerable debate as to which method is more accurate for measuring the activity of CYP3A in vivo: cortisol 6β-hydroxylation clearance (Clm(6β)) or the urinary ratio of 6β-OHF to F (6β-OHF/F). Furthermore, the value of measuring endogenous levels of cortisol over a 24 h period (AUCF) needs to be confirmed. The aim of the present study was to determine which method was most effective at measuring changes in the in vivo activity of CYP3A: AUCF, Clm(6β), or 6β-OHF/F.
Methods:
A two phase, cross-over design was adopted in this study. A total of 24 subjects (12 males and 12 females) were randomly assigned to one of two groups: the test group subjects were given 250 mg clarithromycin tablets twice a day for a period of 4 d, whereas the control group received a placebo twice daily for a similar period. On d 5 of the study, the last dose of either clarithromycin or placebo was supplemented with an oral dose of 7.5 mg midazolam (MDZ); blood and urine samples were then collected at various times. All samples collected at the same sampling times on d 4 were used to evaluate the effects of MDZ administration on cortisol levels and metabolism. The ratio of 1-hydroxymidazolam (1-OHMDZ) concentration to MDZ concentration at 1 h (MR) was taken as a measure of the in vivo CYP3A activity. AUCF, Clm(6β), and 6β-OHF/F were also used as biomarkers for CYP3A activity.
Results:
No correlations were found (either before or after inhibition) between CYP3A activity and any of the following measures: AUCF, Clm(6β), or 6β-OHF/F (r<0.4, P>0.05). After 4 d of clarithromycin administration, CYP3A activity (MR) decreased by 75% (P=0.000), whereas AUCF increased by 19% (P=0.040), and Clm(6β) and 6β-OHF/F decreased by 54.2% (P=0.000) and 50% (P=0.003), respectively. No significant changes in AUCF (P=0.178), or in the amount of urinary 6β-OHF (P=0.169), or in F (P=0.391) were found over a 24 h time period, either with or without MDZ administration.
Conclusion:
Although Clm(6β) and 6β-OHF/F can reflect the decline in CYP3A activity, the impression they provide is neither accurate nor complete. AUCF is completely ineffective for evaluating variations in CYP3A activity. MDZ administration had no evident effects on either cortisol metabolism or excretion over a period of 24 h.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, et al. Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Dispos 2002; 30: 883–91.
Krishna DR, Shekar MS . Cytochrome P450 3A: genetic polymorphisms and inter-ethnic differences. Methods Find Exp Clin Pharmacol 2005; 27: 559–67.
Dahl ML . Cytochrome P450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing? Clin Pharmacokinet 2002; 41: 453–70.
Zaigler M, Tantcheva-Poor I, Fuhr U . Problems and perspectives of phenotyping for drug-metabolizing enzymes in man. Int J Clin Pharmacol Ther 2000; 38: 1–9.
Streetman DS, Bertino JS, Nafziger AN . Phenotyping of drug-metabolizing enzymes in adults: a review of in vivo cytochrome P450 phenotyping probes. Pharmacogenetics 2000; 10: 187–216.
Zhu B, Ou-Yang DS, Cheng ZN, Huang SL, Zhou HH . Sing plasma sampling to predict oral clearance of CYP3A probe midazolam. Acta Pharmacol Sin 2001; 22: 634–38.
Galteau MM, Shamsa F . Urinary 6β-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals. Eur J Clin Pharmacol 2003; 59: 713–33.
Chen YC, Gotzkowsky SK, Nafziger AN, Kulawy RW, Rocci ML, Bertino JS, et al. Poor correlation between 6-hydroxycortisol: cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity. Br J Clin Pharmacol 2006; 62: 187–95.
Kinirons MT, O Shea D, Downing TE, Fitzwilliam AT, Joellenbeck L, Groopman JD, et al. Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men. Clin Pharmacol Ther 1993; 54: 621–9.
Hunt CM, Watkins PB, Saenger P, Stave GM, Barlascini N, Watlington CO, et al. Heterogeneity of CPY3A isoforms metabolizing erythromycin and cortisol. Clin Pharmacol Ther 1992; 51: 18–23.
Furuta T, Suzuki A, Mori C, Shibasaki H, Yokokawa A, Kasuya Y . Evidence for the validity of cortisol 6β-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans. Drug Metab Dispos 2003; 31: 1283–7.
Hu Z, Gong Q, Hu X, Wang L, Cao Y, Cao W, et al. Simultaneous determination of 6β-hydroxycortisol and cortisol in human urine and plasma by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity. J Chromatogr B 2005; 826: 238–43.
Eeckhoudt SL, Desager JP, Horsmans Y, De Winne AJ, Verbeeck RK . Sensitive assay for midazolam and its metabolite 1′-hydroxymidazolam in human plasma by capillary high-performance liquid chromatography. J Chromatogr B 1998; 710: 165–71.
Abel SM, Maggs JL, Back DJ, Park BK . Cortisol metabolism by human liver in vitro-I. Metabolite identification and inter-individual variability. J Steroid Biochem Mol Biol 1992; 43: 713–9.
Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, et al. Human P-glycoprotein transports cortisol, aldosterone, and dexamethazone, but not progesterone. J Biol Chem 1992; 267: 24248–52.
Tolle-Sander S, Rautio J, Wring S, Polli JW, Polli JE . Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate. Pharm Res 2003; 20: 757–64.
Custodio JM, Wu CY, Benet LZ . Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Advanced Drug Delivery Rev 2008; 60: 717–33.
Szucs N, Varga I, Patocs A, Toth M, Glaz E, Racz K . Secretion of 6β-hydroxycortisol by normal human adrenals and adrenocortical adenomas. Steroids 2003; 68: 477–82.
Kertesz A, Godo G, Falkay G, Boros M . Plasma cortisol, prolactin and thyroxine levels related to midazolam anaesthesia. Acta Med Hung 1986; 43: 283–9.
Misiolek H, Wojcieszek E, Dyaczynska-Herman A . Comparison of influence of thiopentone, propofol and midazolam on blood serum concentration of noradrenaline and cortisol in patients undergoing non-toxic struma operation. Med Sci Monit 2000; 6: 319–24.
Acknowledgements
The work was supported by the Health Department of Hu-nan Province.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luo, X., Li, Xm., Hu, Zy. et al. Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism. Acta Pharmacol Sin 30, 1323–1329 (2009). https://doi.org/10.1038/aps.2009.116
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2009.116
Keywords
This article is cited by
-
Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches
Clinical Pharmacokinetics (2019)
-
Prediction of tacrolimus metabolism and dosage requirements based on CYP3A4 phenotype and CYP3A5*3 genotype in Chinese renal transplant recipients
Acta Pharmacologica Sinica (2016)
